No increased in utero and peripartum HIV acquisition risk in HIV-exposed preterm infants
- PMID: 37928500
- PMCID: PMC10623649
- DOI: 10.4102/sajhivmed.v24i1.1509
No increased in utero and peripartum HIV acquisition risk in HIV-exposed preterm infants
Abstract
Background: Limited data exist on the differential risk of HIV acquisition between infants born preterm versus those born at term to women living with HIV (WLHIV). With a reported increase in preterm delivery among pregnant WLHIV, understanding the risk of vertical transmission of HIV in preterm infants can inform strategies to optimise the timing of diagnostic testing, antiretroviral prophylaxis, and infant feeding.
Objectives: To describe the prevalence and timing of HIV acquisition, in utero versus perinatal, among infants with perinatal HIV exposure born prior to 37 weeks completed gestation age compared to those born at term in the Botswana-based Mpepu study and explore predictors of infant HIV acquisition.
Method: Using data extracted from the Mpepu study, we describe the prevalence, timing and risk factors for HIV acquisition in infants born preterm versus those born at term. Fisher exact testing was used to test for differences in prevalence and timing of HIV and a multivariable logistic regression model was used to assess risk factors for infant HIV acquisition.
Results: 2866 infants born to WLHIV were included in this secondary analysis. 532 (19%) were born preterm. There was no observed difference in the prevalence of HIV acquisition among infants born preterm versus at term overall (0.8% vs 0.6%, P = 0.54), at birth (0.2% vs 0.3%, P = 1.00) or between 14 and 34 days post-delivery (0.6% vs 0.3%, P = 0.41). The absence of maternal antiretroviral use during pregnancy significantly predicted infant HIV acquisition, with the risk of HIV acquisition reduced by 96% among infants whose mothers were taking antiretroviral treatment (ART) during pregnancy (adjusted odds ratio: 0.003, confidence interval: 0.01-0.02, P < 0.001).
Conclusion: There was no observed increase of in utero and peripartum HIV acquisition among infants born preterm following foetal exposure to HIV compared to those born at term.
Keywords: HIV acquisition risk; antiretroviral treatment; preterm neonates; vertical transmission; women living with HIV.
© 2023. The Authors.
Conflict of interest statement
The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.
Similar articles
-
Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.Pediatrics. 2007 Apr;119(4):e900-6. doi: 10.1542/peds.2006-1123. Epub 2007 Mar 12. Pediatrics. 2007. PMID: 17353299
-
[Side effects of antiretroviral treatment for transmission prophylaxis in preterm and near-term infants].Z Geburtshilfe Neonatol. 2007 Dec;211(6):230-5. doi: 10.1055/s-2007-981405. Z Geburtshilfe Neonatol. 2007. PMID: 18176903 German.
-
Congenital Co-infections Among HIV-Exposed Infants Born to Mothers on Antiretroviral Treatment in the United States.Front Pediatr. 2022 Jun 16;10:894627. doi: 10.3389/fped.2022.894627. eCollection 2022. Front Pediatr. 2022. PMID: 35783327 Free PMC article.
-
Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants.Cochrane Database Syst Rev. 2018 Dec 12;12(12):CD012519. doi: 10.1002/14651858.CD012519.pub2. Cochrane Database Syst Rev. 2018. PMID: 30548483 Free PMC article.
-
Adverse perinatal outcomes associated with antiretroviral therapy in women living with HIV: A systematic review and meta-analysis.Front Med (Lausanne). 2023 Feb 3;9:924593. doi: 10.3389/fmed.2022.924593. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36816720 Free PMC article.
References
-
- Centers for Disease Control and Prevention . Introduction of routine HIV testing in prenatal care – Botswana, 2004. MMWR Morb Mortal Wkly Rep. 2004;53(46):1083–1086. - PubMed
-
- Ministry of Health (MoH), Botswana . Handbook of the Botswana 2016 integrated HIV clinical care guidelines. 2016. Gaborone: Botswana MoH.
-
- The Joint United Nations Programme on HIV/AIDS (UNAIDS) . Ending AIDS: Progress towards the 90–90–90 targets. 2017. Geneva: UNAIDS.
-
- Botswana National AIDS Coordinating Agency (NACA) . Progress report of the national response to the 2011 declaration of commitments on HIV and AIDS. 2015. Gaborone: NACA.
Grants and funding
LinkOut - more resources
Full Text Sources